Literature DB >> 18046141

Nipple reconstruction using the modified top hat flap with banked costal cartilage graft: long-term follow-up in 58 patients.

Ming-Huei Cheng1, Eduardo D Rodriguez, James M Smartt, Alexander Cardenas-Mejia.   

Abstract

The long-term projection of nipple reconstruction is a challenge. Fifty-eight consecutive female patients underwent 58 nipple reconstructions with modified top hat flap with cartilage graft following breast reconstruction in 54 autologous tissues and 4 implants, respectively. The average neonipple size was 11.5 mm initially and 8.5 mm at a mean follow-up of 44.9 months (range, 24-65 months), with a mean decrease in projection of 26.1%. Thirty-three patients achieved an excellent result, 20 patients a good result, 3 patients a fair result, and 2 patients a poor result, respectively. The complication rate was 12.1% (7 of 58 cases), and there was no statistically significant difference between the immediate and delayed groups; the revision rate was 8.6% (5 of 58 cases). The modified top hat flap with banked costal cartilage graft provides a sustainable solution to the gradual loss of nipple projection, with few complications.

Entities:  

Mesh:

Year:  2007        PMID: 18046141     DOI: 10.1097/SAP.0b013e318048573c

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  4 in total

1.  Reducing donor site morbidity when reconstructing the nipple using a composite nipple graft.

Authors:  Taik Jong Lee; Hyung Joo Noh; Eun Key Kim; Jin Sup Eom
Journal:  Arch Plast Surg       Date:  2012-07-13

Review 2.  Nipple-areola complex reconstruction.

Authors:  Anongporn Nimboriboonporn; Suebwong Chuthapisith
Journal:  Gland Surg       Date:  2014-02

3.  Biologic collagen cylinder with skate flap technique for nipple reconstruction.

Authors:  Brian P Tierney; Jason P Hodde; Daniela I Changkuon
Journal:  Plast Surg Int       Date:  2014-07-10

Review 4.  Nipple-Areola Complex Reconstruction.

Authors:  Andrea Sisti
Journal:  Medicina (Kaunas)       Date:  2020-06-16       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.